Saavedra, Kristel Jane S.

HRN: 18-16-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2026
CO-AMOXICLAV 625MG (TAB)
03/30/2026
04/05/2026
PO
625mg
TID
UTI
Checking Initial Appropriateness 
03/31/2026
CEFAZOLIN 1GM (VIAL)
03/31/2026
03/31/2026
IV
2g
PTOR
STAT CS
Checking Initial Appropriateness 
03/31/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
03/31/2026
03/31/2026
IV
240 Mg
OD
S/P CS
Checking Initial Appropriateness 
03/31/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/31/2026
04/01/2026
IV
900mg
Q8hrs
S/P CS
Checking Initial Appropriateness 
03/31/2026
CLINDAMYCIN 300MG (CAP)
04/01/2026
04/04/2026
ORAL
300mg
TID
S/P CS
Checking Initial Appropriateness 
03/31/2026
MUPIROCIN 2%, 15G (TUBE)
03/31/2026
04/07/2026
TOPICAL
2%
BID
S/P CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: